title: The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy.
abstract: We prepared and evaluated transferrin (Tf) and monoclonal antibody (mAb) 2C5-modified dual ligand-targeted poly(ethylene glycol)-phosphatidylethanolamine micelles loaded with a poorly soluble drug, R547 (a selective adenosine triphosphate-competitive cyclin-dependent kinase inhibitor) for enhancement of targeting efficiency and cytotoxicity in vitro and in vivo to A2780 ovarian carcinoma compared to single ligand-targeted micelles. Micellar solubilization significantly improved the solubility of R547 from 1 to 800 μg/mL. The size of modified and non-modified micelles was 13-16 nm. Flow cytometry indicated significantly enhanced cellular association of dual ligand-targeted micelles compared to single ligand-targeted micelles. Confocal microscopy confirmed the Tf receptor-mediated endocytosis of rhodamine-labeled Tf-modified micelles after staining the micelle-treated cells with the endosomal marker Tf-Alexa488. The optimized dual-targeted micelles enhanced cytotoxicity in vitro against A2780 ovarian cancer cells compared to plain and single ligand-targeted micelles. Interestingly, in vivo anti-tumor efficacy was more pronounced for the preparation with a single-targeting ligand (Tf). The specific combination Tf and mAb 2C5 did not yield the expected increase in efficacy as was observed in vitro. This observation suggests that the relationships between targeting ligands in vivo could be more complex than in simplified in vitro systems, and the results of the optimization process should always be verified in vivo.
authors.affiliation: Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115, USA.
authors.forename: Rupa R
authors.initials: RR
authors.lastname: Sawant
authors.forename: Aditi M
authors.initials: AM
authors.lastname: Jhaveri
authors.forename: Alexander
authors.initials: A
authors.lastname: Koshkaryev
authors.forename: Farooq
authors.initials: F
authors.lastname: Qureshi
authors.forename: Vladimir P
authors.initials: VP
authors.lastname: Torchilin
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000627:therapeutic use*; D002478:Cells, Cultured; D004354:Drug Screening Assays, Antitumor; D005434:Flow Cytometry; D006801:Humans; D008024:Ligands; D008823:Micelles; D018613:Microscopy, Confocal; D009369:Neoplasms / Q000188:drug therapy*; D012995:Solubility
chemical_list: D000970:Antineoplastic Agents; D008024:Ligands; D008823:Micelles